Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 4 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Oxaliplatin 47 Cisplatin 43 Fluorouracil 42 Capecitabine 41 pembrolizumab 31 Leucovorin 28 Docetaxel 22 Irinotecan 19 Paclitaxel 18 Trastuzumab 17 Bevacizumab 12 Ramucirumab 11 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 Nivolumab 7 S 1 (combination) 6 Epirubicin 6 Carboplatin 6 Sunitinib 4 Platinum 4 Mitomycin 4 trastuzumab deruxtecan 3 olaparib 3 epacadostat 3 bemarituzumab 3 Pemetrexed 3 Ipilimumab 3 Folfox protocol 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡